Navigation Links
Keryx Biopharmaceuticals Announces Additions to Management Team
Date:2/15/2008

Key Hires in Quality Operations and Medical Affairs

NEW YORK, Feb. 15 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Lou DeBergalis has joined the Company as Vice President, Quality Operations. Keryx also announced that Eric Grossman, MD, will join the Company later this month in the role of Vice President, Medical Affairs. Both Mr. DeBergalis and Dr. Grossman will report directly to Michael S. Weiss, Chief Executive Officer.

Commenting on the recent hires of Mr. DeBergalis and Dr. Grossman, Michael S. Weiss, the Company's Chairman and Chief Executive Officer, stated, "We are delighted to welcome Lou and Eric to the Keryx team. Each has exceptional experience in the pharmaceutical industry and brings a significant level of expertise to our quality operations and medical affairs as we continue to build the corporate infrastructure to manage both the potential launch of Sulonex and the future development and commercialization of our other drug candidates."

As Vice President, Quality Operations, Mr. DeBergalis will assume overall strategic and operational responsibility for all Quality Operations (clinical, non-clinical and manufacturing), including both quality control and quality assurance.

Mr. DeBergalis joins Keryx following his retirement from Pfizer Inc. in July 2007 as Vice-President Quality Operations - Europe/Ireland/Singapore, responsible for the operational, administrative, and regulatory aspects of quality in Pfizer's manufacturing sites in those geographic areas. During his 36 years in the Pfizer organization, Mr. DeBergalis held roles of increasing responsibility in both its Global Manufacturing and Quality Control Divisions in Pfizer's New York C
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
2. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
9. Nabi Biopharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference
10. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals Stockholders Approve Asset Sale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Earlier this year in a June 24 international ... Stem Cell Technology Center, LLC ( ASCTC ) focused attention ... adult tissue stem cells. His title “Asymmetric Self-Renewal by ... Future,” embodied the essence of his message to congress participants. ...
(Date:12/24/2014)... On Friday, December 19, 2014, President ... Continuing Resolution Appropriations Act of 2015, which for the ... funding through the Congressionally Directed Medical Research Programs (CDMRP) ... Association (HA), working in conjunction with its allies on ...
(Date:12/24/2014)... Texas (PRWEB) December 23, 2014 ... such as its definition, classification, application and industry ... process, and product cost structure. Production is separated ... covers upstream raw materials, equipment, downstream client survey, ...
(Date:12/24/2014)... December 24, 2014 The report expects global ... 2019. It also provides a carefully analyzed data about the ... market. , Full Copy of Report @ http://bit.ly/1yUxy0T ... expansion will keep witnessing growth at an impressive CAGR during ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
... are Honored ... Meeting, Laguna Niguel, LAGUNA NIGUEL, Calif., Oct. 8 ... CEO-only conference hosted by,Burrill & Company and Kleiner Perkins Caufield ... at an Awards Dinner held here Sunday,evening. For twenty ...
... BERKELEY HEIGHTS, N.J., Oct. 8 Clinsys ... organization,today announced the relocation of its corporate ... plans for future expansion. The new,larger facility ... "Our new headquarters, combined with our recent ...
... Demonstrates USC,s Increased Commitment to Research Advancements in ... Robust Life Science Industry in Los Angeles, ... the University of Southern California,s strengthened,commitment to advancing breakthrough ... announced today the opening of an office,in the new ...
Cached Biology Technology:Biotech Hall of Fame Inductees Announced 2Biotech Hall of Fame Inductees Announced 3Biotech Hall of Fame Inductees Announced 4Biotech Hall of Fame Inductees Announced 5Biotech Hall of Fame Inductees Announced 6Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters 2The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus 2The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus 3The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus 4
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today announced the ... ancestry of individuals from across the United States ... four hundred years ago, the United States ... different continents. This study illuminates how American history and the ...
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ...
(Date:12/11/2014)... 2014 Research and Markets , ... has announced the addition of the "Biometrics Market ... One major trend emerging in this market ... systems utilize more than one characteristic of an individual ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Myelin-making Schwann cells have an ability every aging Hollywood ... to a study appearing in the May 19 issue ... B. Parkinson (University College London, London, UK) and collogues ... to their youth, a finding that might help researchers ...
... Life-affiliated scientists, plumbing the secrets of a vast underwater ... images of a novel Brittlestar City established against daunting ... underwater summit taller than the worlds tallest building. ... tip to arm tip, owe their success to the ...
... 2008) -- Dr. Kristina M. Johnson, provost and senior ... recently received the John Fritz Medal from the American ... woman so honored. Johnson was one of seven ... the Great Hall of the National Academy of Engineering ...
Cached Biology News:Explorers marvel at 'Brittlestar City' on seamount in powerful current swirling around Antarctica 2Explorers marvel at 'Brittlestar City' on seamount in powerful current swirling around Antarctica 3Explorers marvel at 'Brittlestar City' on seamount in powerful current swirling around Antarctica 4IEEE Fellow first woman to receive highest award in engineering profession 2IEEE Fellow first woman to receive highest award in engineering profession 3IEEE Fellow first woman to receive highest award in engineering profession 4IEEE Fellow first woman to receive highest award in engineering profession 5
... Moticam 2300 camera (MC2300) attaches to virtually ... trinocular port. Included in the standard package, ... software offers quick and accurate image capture, ... for examination or documentation purposes. The MC2300s ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
... StabilZyme NOBLE BSA-Free Stabilizer is a ... Stabilizer. It is an aqueous ... in a MOPS buffer (3-(N-Morpholino) propanesulfonic ... contains a combination of 0.02% methylisothiazolone ...
...
Biology Products: